CNC - Centene Corporation

NYSE - NYSE Delayed Price. Currency in USD
60.02
+0.04 (+0.07%)
At close: 4:03PM EST

60.02 0.00 (0.00%)
After hours: 4:32PM EST

Stock chart is not supported by your current browser
Previous Close59.98
Open60.00
Bid60.05 x 1200
Ask60.20 x 1000
Day's Range59.23 - 60.22
52 Week Range41.62 - 70.00
Volume2,702,938
Avg. Volume5,019,298
Market Cap24.836B
Beta (3Y Monthly)0.91
PE Ratio (TTM)18.59
EPS (TTM)3.23
Earnings DateFeb 4, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est70.18
  • PR Newswire

    Centene and WellCare Receive State Approvals for Pending Merger from Illinois and New Jersey

    Centene Corporation (NYSE: CNC) ("Centene") and WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") today announced that the Illinois Department of Insurance, the New Jersey Department of Banking and Insurance and the New Jersey Division of Medical Assistance and Health Services have each approved Centene's indirect pending acquisition of WellCare domestic insurers in those respective states. Completion of the transaction remains subject to clearance under the Hart-Scott-Rodino Act, approval of the divestitures of legal entities in the states of Illinois and Nebraska, and other customary closing conditions.

  • David Tepper Trims UnitedHealth, Exits Intelsat
    GuruFocus.com

    David Tepper Trims UnitedHealth, Exits Intelsat

    Investor's largest sales of the 3rd quarter Continue reading...

  • Humana (HUM) vs. Anthem (ANTM): Which is Better Placed?
    Zacks

    Humana (HUM) vs. Anthem (ANTM): Which is Better Placed?

    Humana (HUM) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On a comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

  • Centene (CNC) Divests IlliniCare as Part of Merger Agreement
    Zacks

    Centene (CNC) Divests IlliniCare as Part of Merger Agreement

    Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.

  • CVS Health Set to Acquire Centene's IlliniCare Health Plan
    Zacks

    CVS Health Set to Acquire Centene's IlliniCare Health Plan

    CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.

  • PR Newswire

    Centene Corporation Announces Extension of Exchange Offers and Consent Solicitations for WellCare Notes

    Centene Corporation (NYSE:CNC) ("Centene") announced today the extension of the expiration date of the offers to exchange (the "Exchange Offers") notes (the "WellCare Notes") issued by WellCare Health Plans, Inc. (NYSE:WCG) ("WellCare") for up to $1,950,000,000 aggregate principal amount of new notes to be issued by Centene (the "Centene Notes") and cash and the related consent solicitations (the "Consent Solicitations") being made by Centene on behalf of WellCare to adopt certain proposed amendments (the "Amendments") to the indentures governing the WellCare Notes. Centene hereby extends such expiration date from 5:00 p.m., New York City time, on December 2, 2019, to 5:00 p.m., New York City time, on December 18, 2019 (as the same may be further extended, the "Expiration Date").

  • Should You Care About Centene Corporation’s (NYSE:CNC) Investment Potential?
    Simply Wall St.

    Should You Care About Centene Corporation’s (NYSE:CNC) Investment Potential?

    Today we'll evaluate Centene Corporation (NYSE:CNC) to determine whether it could have potential as an investment...

  • Why Should You Hold Centene (CNC) Stock in Your Portfolio?
    Zacks

    Why Should You Hold Centene (CNC) Stock in Your Portfolio?

    Acquisitions, rising revenues, growing membership and solid capital position carve out a long-term growth story for Centene (CNC).

  • Reuters

    UPDATE 2-Centene to sell Illinois health plan unit to CVS to aid merger with WellCare

    Health insurer Centene Corp said on Monday it had entered an agreement to sell its Illinois unit to CVS Health Corp, moving a step closer to closing its $15.27 billion deal to buy smaller rival WellCare Health Plans Inc. Centene expects to scale up its government-backed Medicare and Medicaid businesses with the WellCare deal, but in some states Medicaid divestitures may be required, such as Georgia and Illinois, Wall Street analysts had pointed out. In September, following the U.S. Department of Justice's demand for additional information regarding the merger, WellCare agreed to sell its Missouri and Nebraska Medicaid plan units due to significant overlap in business in the states with Centene.

  • PR Newswire

    Centene and CVS Health Announce Agreement for CVS Health to Acquire IlliniCare Health

    Centene Corporation (NYSE: CNC) ("Centene") and CVS Health (NYSE: CVS) announced today that, in connection with the previously announced merger agreement between Centene and WellCare Health Plans, Inc. (NYSE: WCG), Centene has entered into a definitive agreement under which CVS Health will acquire Centene's Illinois health plan subsidiary, IlliniCare Health Plan, Inc. ("IlliniCare"). The transaction entails the sale of Centene's Medicaid and Medicare Advantage lines of business in Illinois.

  • Did Hedge Funds Drop The Ball On Centene Corp (CNC) ?
    Insider Monkey

    Did Hedge Funds Drop The Ball On Centene Corp (CNC) ?

    How do we determine whether Centene Corp (NYSE:CNC) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that […]

  • PR Newswire

    Centene Corporation Prices Offering of Senior Notes

    The $7,000,000,000 of senior notes will include $1,000,000,000 aggregate principal amount of additional 4.750% senior notes due 2025 (the "Additional 2025 Notes") at a premium to yield 3.76%, $2,500,000,000 aggregate principal amount of new 4.250% senior notes due 2027 (the "2027 Notes") at a discount to yield 4.375% and $3,500,000,000 aggregate principal amount of new 4.625% senior notes due 2029 (the "2029 Notes" and, together with the Additional 2025 Notes and the 2027 Notes, the "Notes"). The Additional 2025 Notes will have the same terms as the Company's existing 4.750% senior notes due 2025 (the "Existing 2025 Notes"), other than the issue date, the issue price, transfer restrictions, certain related registration rights and certain other limited exceptions. The Additional 2025 Notes priced at 102.875% of the principal amount thereof, the 2027 Notes priced at 99.160% of the principal amount thereof and the 2029 Notes priced at 100.000% of the principal amount thereof, which together will result in aggregate gross proceeds of $7,007,750,000.

  • Why Is Centene (CNC) Up 22.9% Since Last Earnings Report?
    Zacks

    Why Is Centene (CNC) Up 22.9% Since Last Earnings Report?

    Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Kings clarify planning for Natomas arena re-use
    American City Business Journals

    Kings clarify planning for Natomas arena re-use

    A poster mounted at a community meeting listed several possible uses for the 180-acre current site of the dormant Sleep Train Arena: An amusement park, a college campus, a major medical center, a residential care facility.

  • Managed care stocks jump on Warren’s 2022 Medicare for All plans
    MarketWatch

    Managed care stocks jump on Warren’s 2022 Medicare for All plans

    Stocks of health care providers and health insurers are rallying after Sen. Elizabeth Warren said Friday that she plans to hold off on Medicare for All legislation until the third year in her presidential term.

  • Call Buyers Keep Betting on Booming Centene Stock
    Schaeffer's Investment Research

    Call Buyers Keep Betting on Booming Centene Stock

    CNC is pacing for its best close in months

  • Healthcare Stocks in Focus on  Price Transparency Rule
    Zacks

    Healthcare Stocks in Focus on Price Transparency Rule

    Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.

  • Market Weekly Review: Healthcare Leads the Way Higher
    TipRanks

    Market Weekly Review: Healthcare Leads the Way Higher

    The broader U.S. market averages all closed at record highs on Friday, as bulls won out again this week. Healthcare stocks led the way higher this week, while Energy names lagged.Looking ahead to next week, the retail sector will dominate the waning days of earnings season, led by Home Depot (HD), Macy’s (M) and Target (TGT).On one hand, equities are at all-time highs; but on the other, third-quarter earnings are on pace to decline from the previous year.On Thursday, strategists at Morgan Stanley chimed in on Thursday, about how they expect the next major market shift could play out:“We think Value's performance relative to Growth is bottoming after 13 years of underperformance. We see a two-step process that plays out over an extended investment horizon: Growth's underperformance drives Part 1, and then Value's outperformance drives Part 2. In between, there’s a recession. To be clear, our economists are not making a call on the timing of the next downturn. However, the current late-cycle environment isn't likely to last forever, and we believe that investors should look ahead to the coming regime shift.”Knowing what and when to buy can be challenging for any investor. However, the fact remains that attractive investments are out there, if you’re willing to dig a little deeper.One such healthcare name that has a little bit to offer both growth and value investors is worth a closer look and is our Stock of the Week below… Stock of the Week: Centene (CNC)The company provides managed care health insurance to about 15 million customers, across 32 states and three different countries.The stock gained 4% this week, as healthcare names led the market to new record highs.Looking ahead, these gains should keep on coming. Here’s why:Centene has strong operating momentum, as evidenced by the better-than-expected quarterly results delivered by management on Oct. 22. The company earned $0.96 a share in the third quarter, as revenue increased 17% from the previous year, to $18.98 billion.Centene posted 6% member growth in the period, building its leadership position in the government-sponsored healthcare market, such as Medicaid and Medicare. This position will be further bolstered by the company’s pending merger with Wellcare Health (WCG), which is expected to close in the first half of 2020.Management confirmed this favorable outlook on Tuesday, with an upbeat message at the Credit Suisse Healthcare conference. Wall Street agrees, as 4 of the 5 active analysts on Wall Street rate the shares a Buy. The average price target of $65.20 represents another 13.3% upside potential to current levels. In the meantime, the stock appears to offer growth at a reasonable price. Centene is currently valued at just 11.7x expected full-year earnings of $4.94 a share. This is both a discount to the overall market and industry average valuation of 13.4x. It also compares favorably to the 16.7% annual earnings growth the company is expected to average of over the next three years. The hedge fund community is one group that sees value in the shares. Just this week, Bloom Tree Partners and Maverick Capital reported increased stakes in Centene. The company is also putting its money where its mouth is, as management pledged to repurchase $500 million worth of stock last month. The next potential catalyst for Centene is its upcoming Financial Guidance and Investor Day, on Dec. 13.FYI: This is just 1 of the 20+ stocks selected for the Smart Investor portfolio. That’s where we share more detailed insights on our weekly stock picks. You may also want to learn more about how we use TipRanks indicators to find stocks that are primed to outperform. Discover the Smart Investor portfolio here >>Wishing you a world of investment success!

  • Bloomberg

    Warren Maps 3-Year Timeline Toward Medicare for All; Stocks Rise

    (Bloomberg) -- Elizabeth Warren said Friday her Medicare-for-All plan would be implemented over three years, a major concession to the difficulty of fundamentally changing the way Americans get health care. Managed-care and hospital stocks moved higher on the news.A Medium post Warren published Friday mapped out a strategy to enact a mandatory government-run health care system that she estimates would cost $20.5 trillion but others have tagged at more than $30 trillion.Warren said she would inch up to Medicare-for-all, starting with a plan to cover children and poor families. That would happen through a legislative maneuver in her first 100 days in the White House, while not actually eliminating private insurance plans until her third year in office.Health-care companies, which worried about extinction, rallied Friday, leading the S&P 500 Health Index to an all-time high. Among them, some of the nation’s largest insurers such as UnitedHealth Group Inc., Humana Inc., Anthem Inc. and Centene Corp. have climbed more than 5% in Friday’s trading.The advance in health care is a turnaround from the first nine months of the year, when the industry trailed most of its market peers over drug-pricing regulations and Medicare for All proposals.Even if Warren wins the White House and Democrats win control of both the House and Senate, Warren’s timeline is still optimistic, given how Congress operates.She said she would ask Congress to use a quirk in the budget process to allow a simple majority vote -- bypassing the 60-vote Senate threshold -- and “fast-track” a Medicare for All option that would immediately cover children under the age of 18 and families making less than $51,000 a year, and provide an option for expanded Medicare for people over 50.In the first three years, anyone else could buy into Medicare for All at a “modest” cost, Warren said, before it eventually became free.By her third year in office, Warren said, “the American people will have experienced the full benefits of a true Medicare for All option, and they can see for themselves how that experience stacks up against high-priced care that requires them to fight tooth-and-nail against their insurance company.”She added, “I won’t hand Mitch McConnell a veto over my health care agenda,” referring to the current Senate majority leader.After repeated questioning about how she would finance a government-run Medicare for All system that eliminates private insurance, Warren on Nov. 1 rolled out a $20.5 trillion proposal funded by taxing the rich and large corporations.Her gradual implementation “will give people time to adjust, people in the industry will have time to look for other jobs, pension plans will have time to start changing their portfolio and it will give the government time to gear up the bureaucracy,” said Gerald Friedman, professor of economics at the University of Massachusetts at Amherst, who consulted on Bernie Sanders’s 2016 presidential campaign on Medicare for All, the basis of Warren’s plan.The new proposal sets Warren apart from Sanders, who has said he wouldn’t compromise with incremental health-care changes.But Friedman cautioned that a long transition period could leave the private health insurance industry in shambles.“If you know that in three years your company is going to be wiped out, then it could create perverse incentives, staff start exiting and companies may become dysfunctional before the government program is set up,” Friedman said.Warren’s new proposal at least at first ends up looking much like that of her moderate rivals, Joe Biden and Pete Buttigieg: Expanded government-run insurance without mandating it for everyone.Spokesmen for Biden and Buttigieg quickly weighed in.“Senator Warren is now trying to muddy the waters even further,” said deputy campaign manager Kate Bedingfield. “We’re not going to beat Donald Trump next year with double talk on health care.”Buttigieg spokeswoman Lis Smith said, “Senator Warren’s new health care ’plan’ is a transparently political attempt to paper over a very serious policy problem, which is that she wants to force 150 million people off their private insurance -- whether they like it or not.”Even if Democrats control the entire federal government in 2021, their best-case scenario is a narrow Senate majority that would likely leave Warren far short of the votes to pass Medicare for All. And several key Democrats have pledged not to eliminate the legislative filibuster. But the party is more united around the idea of a government-run insurance option.The budget fast-track process, known as reconciliation, has been used by majorities in both parties to avoid a filibuster. Democrats under President Barack Obama used it to pass Obamacare in 2010, while Republicans under President Donald Trump tried to use the procedure to repeal the health-care law in 2017 but came up short.“While Republicans tried to use fast-track budget reconciliation legislation to rip away health insurance from millions of people with just 50 votes in the Senate, I’ll use that tool in reverse – to improve our existing public insurance programs,” Warren wrote.Still, budget reconciliation creates complications as Senate rules require that such legislation be limited to changes involving taxes and spending. Republicans struggled to shoehorn their attempted repeal of Obamacare, which included regulatory reforms, into the process.Warren also vowed to take immediate action to lower drug prices in her first day as president, including insulin, EpiPens and drugs that save people from opioid overdoses. A Warren administration would help companies produce expensive medicines as a price-control measure and use administrative authority to ensure sufficient supply.(Updates with details in first, second, third paragraphs.)\--With assistance from Tatiana Darie.To contact the reporters on this story: Misyrlena Egkolfopoulou in Washington at megkolfopoul@bloomberg.net;Sahil Kapur in Washington at skapur39@bloomberg.netTo contact the editor responsible for this story: Wendy Benjaminson at wbenjaminson@bloomberg.netFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Stock Market Live Updates: DOW 28,000
    Yahoo Finance

    Stock Market Live Updates: DOW 28,000

    Headlines moving the stock market in real time.

  • PR Newswire

    Centene Corporation Announces Offering of Senior Notes

    Centene intends to use the net proceeds of the New Notes to finance the cash consideration payable in connection with Centene's previously announced acquisition of WellCare Health Plans, Inc. ("WellCare") and to pay related fees and expenses. Centene expects to use the net proceeds of the 2026 Notes for general corporate purposes, including the repayment of revolver borrowings. Centene currently expects the acquisition to be completed by the first half of 2020.

  • Kitzhaber worries about future of Oregon's Medicaid model
    American City Business Journals

    Kitzhaber worries about future of Oregon's Medicaid model

    Former Gov. John Kitzhaber, the architect of Oregon’s coordinated care organizations for managing Medicaid, said he’s concerned about the system’s future. Kitzhaber shared a frank assessment of what he views as a lack of direction and burdensome new rules and penalties. Fifteen CCOs manage about 1 million people on Medicaid, or a quarter of the state's population.

  • Second hotel planned on Advantage Way in North Natomas
    American City Business Journals

    Second hotel planned on Advantage Way in North Natomas

    Sacramento’s Natomas area is getting a ninth new hotel, directly north of one about to start construction.

  • Here's Why I Think Centene (NYSE:CNC) Is An Interesting Stock
    Simply Wall St.

    Here's Why I Think Centene (NYSE:CNC) Is An Interesting Stock

    For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

  • MoneyShow

    Sam Stovall's "Outlook" for November

    October is over, much to the delight of investors, mainly because it historically experienced 37% greater monthly price fluctuations than the average for the other 11 months since 1945, notes analyst Sam Stovall, chief investment strategist for CFRA Research's The Outlook.